Related Experiment Video
Updated: Sep 26, 2026

Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
Safety and success of exhaled breath condensate collection in asthma
1Department of Pediatrics, Unit of Allergy and Respiratory Medicine, University of Padua, Italy. eugi@pediatria.unipd.it
Insights
Exhaled breath condensate (EBC) is a safe and well-tolerated procedure for assessing airway inflammation in children, even those with asthma exacerbations. The study demonstrated a 100% success rate in children aged 4 and above.
Area of Science:
- Pulmonology
- Pediatric Respiratory Medicine
- Biomarker Discovery
Background:
- Exhaled breath condensate (EBC) is an emerging tool for non-invasively assessing airway inflammation.
- EBC analysis allows for the detection of volatile and non-volatile substances indicative of lower airway conditions.
Purpose of the Study:
- To evaluate the safety and feasibility of the EBC procedure in pediatric patients with asthma.
- To assess the EBC procedure's impact on lung function and fractional exhaled nitric oxide (FE(NO)) in children with asthma.
Main Methods:
- A cross-sectional study involving 18 healthy children and 91 children with asthma (aged 4-17 years).
- Children underwent the EBC procedure without pre-treatment with beta2 agonists.
- Outcomes included procedure completion, changes in FEV1 and FE(NO), and adverse events.
Main Results:
- The EBC procedure was successfully completed by all participants, yielding a 100% success rate in children aged 4 and above.
- A median fall of -1% in FEV1 was observed in asthmatic children, comparable to healthy controls, with only one child experiencing a drop exceeding 12%.
- No significant changes in fractional exhaled nitric oxide (FE(NO)) were detected post-procedure.
Conclusions:
- Exhaled breath condensate (EBC) is a simple, safe, and well-tolerated method for collecting biological samples from the lower airways in children.
- The EBC procedure is feasible and safe for children with asthma, including those experiencing exacerbations.
- EBC offers a valuable, non-invasive approach for evaluating airway inflammation in pediatric populations.
Background:
Exhaled breath condensate (EBC) is a rapidly expanding area of research to study airway inflammation through the detection of volatile and non-volatile substances in the airways.
Aims:
To determine the safety and feasibility of EBC procedure in a group of children with asthma of varying severity.
Methods:
In a cross sectional study of children aged 4-17 years, 18 healthy and 91 asthmatic children (69 in stable condition and 22 with asthma exacerbation) underwent the EBC procedure. Outcomes assessed included completion of the procedure, decrease in FEV1, change in fractional exhaled nitric oxide (FE(NO)), and adverse effects. No pretreatment with beta2 agonists was given. All children were able to successfully complete the EBC procedure.
Results:
Median fall in FEV1 after the procedure was -1% (IQR -3.5, 1.8) in asthmatics and was comparable to that observed in healthy children. In only one asthmatic child did the drop in FEV1 exceed 12%. No significant changes in FE(NO) were observed after EBC.
Conclusion:
This study suggests that EBC is a simple and well tolerated method for evaluating biological samples from the lower airway. The procedure was safe in children with asthma exacerbation, and the success rate was 100% in children aged 4 years and above.
Related Concept Videos
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Physical Assessment of the Respiratory Tract I: Health History
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and key...
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
Breathing
Asthma III: Clinical Manifestations
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...

